Identification and Characterization of an Epigenetic Program that Maintains the Self-Renewal of MLL Myeloid Leukemia Stem Cells |
Stanford University / Hon-Kit Wong |
Young Investigator Grants |
2010 |
California |
APOBEC3 in Pediatric Leukemia: a Biomarker for Sensitivity to PARP Inhibition? |
Children’s Hospital of Philadelphia / Abby Green, MD |
Young Investigator Grants |
2014 |
Pennsylvania |
Epigenomic Mechanisms of Neuroblastoma Tumorigenesis |
Children’s Hospital of Philadelphia / Jo Lynne Harenza, PhD |
Young Investigator Grants |
2017 |
Pennsylvania |
Modeling GATA2 Associated MDS/AML Predisposition Syndrome Using Color-Barcoding and Mutagenesis in Zebrafish |
Dana-Farber Cancer Institute / Serine Avagyan, PhD |
Young Investigator Grants |
2018 |
Massachusetts |
Targeting Aberrant Hh Signaling with BET Bromodomain Inhibition as a Novel Therapeutic Strategy Against MB and DIPG |
Lucile Packard Children’s Hospital at Stanford University School of Medicine / Yujie Tang, PhD |
Young Investigator Grants |
2014 |
California |
A mouse model of Wilms' Tumor
|
Massachusetts General Hospital / Nabeel Bardeesy, PhD |
Young Investigator Grants |
2008 |
Massachusetts |
Promoter Hypermethylation in MLL-Rearranged Leukemias: Biology and Therapeutic Targeting |
The Johns Hopkins University School of Medicine / Eric Schafer |
Young Investigator Grants |
2010 |
Maryland |
Enhancing the Viability, Function, and Safety, of Genetically-Enhanced NK Cells Within the Solid Tumor Microenvironment With IL-15 and a Suicide Gene |
Baylor College of Medicine / Robin Parihar, MD, PhD |
Young Investigator Grants |
2015 |
Texas |
Single-cell RNA-seq Profiling of Transcriptional Transition States During Human Retinoblastoma |
Children’s Hospital Los Angeles / Sunhye Lee, PhD |
Young Investigator Grants |
2016 |
California |
Treatment for human hepatoblastoma based on recombinant adeno-associated virus vectors |
University of Florida / Chen Ling |
Young Investigator Grants |
2012 |
Florida |